The Voice of Rare Disease
Patients in Europe
MEDICAMENTOS HUÉRFANOS
List of the latest marketing authorisations and orphan medicinal products designations
Detailed information on European orphan medicinal products designation applications is available on the EMA website. A full list of designated and authorised orphan medicinal products in Europe available at: ec.europa.eu.
Learn more about the Orphan designation process in Europe
Recent marketing authorisations
Medicinal Product | Marketing Authorisation Holder | Therapeutic Indication | Date of Marketing Authorisation |
Isturisa® (osilodrostat) | Novartis Europharm Limited | Cushing Syndrome | 09/01/2020 |
Polivy® (polatuzumab vedotin) | Roche Registration GmbH | Diffuse large B-cell lymphoma (DLBCL) | 16/01/2020 |
No hay comentarios:
Publicar un comentario